EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM

The review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics abnormalities causing coronary complications....

Full description

Bibliographic Details
Main Author: A. L. Komarov
Format: Article
Language:Russian
Published: «REMEDIUM GROUP» Ltd. 2015-12-01
Series:Атеротромбоз
Subjects:
Online Access:https://www.aterotromboz.ru/jour/article/view/52
_version_ 1797884011622694912
author A. L. Komarov
author_facet A. L. Komarov
author_sort A. L. Komarov
collection DOAJ
description The review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics abnormalities causing coronary complications. It discusses proposals of the international expert organizations on the assessment of sensitivity to clopidogrel and possible modifications of antiplatelet treatment.
first_indexed 2024-04-10T03:59:45Z
format Article
id doaj.art-b50675d4e7ef4d0c805e0bb42bfc12e7
institution Directory Open Access Journal
issn 2307-1109
2658-5952
language Russian
last_indexed 2024-04-10T03:59:45Z
publishDate 2015-12-01
publisher «REMEDIUM GROUP» Ltd.
record_format Article
series Атеротромбоз
spelling doaj.art-b50675d4e7ef4d0c805e0bb42bfc12e72023-03-13T07:10:41Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522015-12-01029510610.21518/2307-1109-2015-2-95-10648EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEMA. L. Komarov0ФГБУ «Российский кардиологический научно-производственный комплекс» Министерства здравоохранения РФ, МоскваThe review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics abnormalities causing coronary complications. It discusses proposals of the international expert organizations on the assessment of sensitivity to clopidogrel and possible modifications of antiplatelet treatment.https://www.aterotromboz.ru/jour/article/view/52фармакогенетикаостаточная реактивность тромбоцитов к адфантиагрегантная терапиячрескожные коронарные вмешательстватромбоз
spellingShingle A. L. Komarov
EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
Атеротромбоз
фармакогенетика
остаточная реактивность тромбоцитов к адф
антиагрегантная терапия
чрескожные коронарные вмешательства
тромбоз
title EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
title_full EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
title_fullStr EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
title_full_unstemmed EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
title_short EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
title_sort evaluation of sensitivity to clopidogrel the current state of the problem
topic фармакогенетика
остаточная реактивность тромбоцитов к адф
антиагрегантная терапия
чрескожные коронарные вмешательства
тромбоз
url https://www.aterotromboz.ru/jour/article/view/52
work_keys_str_mv AT alkomarov evaluationofsensitivitytoclopidogrelthecurrentstateoftheproblem